Table 2.
MR estimates for the causal effect of COVID-19 susceptibility on psychiatric disorder.
| Exposure | Outcome | IVW | Weighted median | MR-Egger | Cochran Q test | MR-Egger | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | Q value | p | Intercept | p | ||
| COVID-19 susceptibility | ASD | 0.971 (0.926, 1.019) | 0.241 | 1.013 (0.978, 1.493) | 0.461 | 1.078 (0.985, 1.618) | 0.241 | 1.077 | 0.583 | −0.008 | 0.229 |
| COVID-19 susceptibility | MDD | 1.044 (0.949, 1.149) | 0.370 | 1.019 (0.896, 1.158) | 0.769 | 1.278 (0.920, 1.776) | 0.239 | 3.913 | 0.417 | −0.019 | 0.296 |
| COVID-19 susceptibility | BID | 0.894 (0.707, 1.130) | 0.351 | 0.840 (0.643, 1.005) | 0.056 | 0.998 (0.396, 2.464) | 0.981 | 8.571 | 0.072 | −0.009 | 0.836 |
| COVID-19 susceptibility | SCZ | 0.971 (0.847, 1.114) | 0.681 | 0.942 (0.816, 1.088) | 0.420 | 1.285 (0.859, 1.923) | 0.308 | 7.472 | 0.112 | −0.028 | 0.248 |
| COVID-19 susceptibility | Anxiety disorder | 1.001 (0.999, 1.002) | 0.341 | 1.005 (0.988, 1.021) | 0.351 | 1.000 (0.998, 1.292) | 0.484 | 4.958 | 0.291 | 0.002 | 0.329 |